Synergy of interleukin 10 and toll‐like receptor 9 signalling in B cell proliferation: Implications for lymphoma pathogenesis

Maren Feist(Universitätsmedizin Göttingen), Dieter Kube(Universitätsmedizin Göttingen), Julia C. Engelmann(Royal Netherlands Institute for Sea Research), Judith Kemper(Universitätsmedizin Göttingen), Michael Hummel(Charité - Universitätsmedizin Berlin), Thorsten Rehberg(University of Regensburg), Wolfram Gronwald(University of Regensburg), Franziska Taruttis(University of Regensburg), Rainer Spang(Howard Hughes Medical Institute)
International Journal of Cancer
September 26, 2016
10.1002/ijc.30444
Cited by 8

Related Papers

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults
|Blood|2011|291
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
|Leukemia|2019|260
Combined chemical shift changes and amino acid specific chemical shift mapping of protein–protein interactions
|Journal of Biomolecular NMR|2007|236